DE69233529D1 - Orale antibakterielle Zusammensetzung und Verfahren zur Verbesserung der Resorption von Penem oder Carbapenem Antibiotika im Magen-Darm-Traktus - Google Patents

Orale antibakterielle Zusammensetzung und Verfahren zur Verbesserung der Resorption von Penem oder Carbapenem Antibiotika im Magen-Darm-Traktus

Info

Publication number
DE69233529D1
DE69233529D1 DE69233529T DE69233529T DE69233529D1 DE 69233529 D1 DE69233529 D1 DE 69233529D1 DE 69233529 T DE69233529 T DE 69233529T DE 69233529 T DE69233529 T DE 69233529T DE 69233529 D1 DE69233529 D1 DE 69233529D1
Authority
DE
Germany
Prior art keywords
penem
absorption
antibacterial composition
improving
gastrointestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233529T
Other languages
English (en)
Other versions
DE69233529T2 (de
Inventor
Osamu Sugita
Yasushi Kanai
Takumi Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3147591A external-priority patent/JP3377219B2/ja
Priority claimed from JP3147791A external-priority patent/JP3178726B2/ja
Priority claimed from JP03147891A external-priority patent/JP3161741B2/ja
Priority claimed from JP03147691A external-priority patent/JP3148263B2/ja
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Publication of DE69233529D1 publication Critical patent/DE69233529D1/de
Application granted granted Critical
Publication of DE69233529T2 publication Critical patent/DE69233529T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/005Enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69233529T 1991-02-01 1992-01-30 Orale antibakterielle Zusammensetzungen und Verfahren zur Verbesserung der Resorption von Penem-oder Carbapenem-Antibiotika im Magen-Darm-Trakt Expired - Fee Related DE69233529T2 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP3147791 1991-02-01
JP3147591A JP3377219B2 (ja) 1991-02-01 1991-02-01 経口抗菌組成物
JP3147791A JP3178726B2 (ja) 1991-02-01 1991-02-01 抗菌剤組成物
JP3147691 1991-02-01
JP03147891A JP3161741B2 (ja) 1991-02-01 1991-02-01 ペネム類の消化管吸収改善剤および改善方法
JP3147591 1991-02-01
JP3147891 1991-02-01
JP03147691A JP3148263B2 (ja) 1991-02-01 1991-02-01 抗菌性組成物

Publications (2)

Publication Number Publication Date
DE69233529D1 true DE69233529D1 (de) 2005-07-14
DE69233529T2 DE69233529T2 (de) 2005-11-24

Family

ID=27459440

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69232598T Expired - Fee Related DE69232598T2 (de) 1991-02-01 1992-01-30 Verwendung von Cilastatin, Glutathione und N-acetyl-L-Cysteine zur Herstellung eines Arzneimittels zur Verbesserung der Resorption von Carbapenem oder Penem Antibiotika im Magen-Darm-Trakt
DE69233529T Expired - Fee Related DE69233529T2 (de) 1991-02-01 1992-01-30 Orale antibakterielle Zusammensetzungen und Verfahren zur Verbesserung der Resorption von Penem-oder Carbapenem-Antibiotika im Magen-Darm-Trakt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69232598T Expired - Fee Related DE69232598T2 (de) 1991-02-01 1992-01-30 Verwendung von Cilastatin, Glutathione und N-acetyl-L-Cysteine zur Herstellung eines Arzneimittels zur Verbesserung der Resorption von Carbapenem oder Penem Antibiotika im Magen-Darm-Trakt

Country Status (5)

Country Link
US (2) US5354748A (de)
EP (2) EP1161947B1 (de)
AT (2) ATE217195T1 (de)
DE (2) DE69232598T2 (de)
ES (2) ES2244529T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650204A1 (en) 1996-12-31 1998-07-09 Harry B. Demopoulos Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
US6365635B1 (en) * 1998-01-13 2002-04-02 Suntory Limited Antibacterial composition for topical administration containing antibiotic
WO2001021175A1 (en) * 1999-09-17 2001-03-29 Suntory Limited Antibacterial medicinal compositions
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
CA2868343A1 (en) * 2011-03-24 2012-09-27 Seachaid Pharmaceuticals, Inc. Vancomycin derivatives
CN103371977A (zh) * 2012-04-25 2013-10-30 秦引林 一种泰比培南酯颗粒及其制备方法
WO2014126594A1 (en) * 2013-02-15 2014-08-21 Guilford Frederick Timothy Treatment of evolving bacterial resistance diseases including klebsiella pneumoniae with liposomally formulated glutathione

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668504A (en) * 1970-11-18 1987-05-26 Merck & Co., Inc. Use of substituted propenoates to prevent nephrotoxicity of certain antibiotics
US4168314A (en) * 1977-11-17 1979-09-18 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
US4301074A (en) * 1977-11-17 1981-11-17 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-substituted-pen-2-em-3-carboxylic acid
US4616038A (en) * 1978-07-24 1986-10-07 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
PH16708A (en) * 1978-07-24 1984-01-20 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
AR244550A1 (es) * 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
US4272437A (en) * 1978-12-18 1981-06-09 Bristol-Myers Company Antibacterial agents, and 4-thio azetidinone intermediates
US4539208A (en) * 1980-09-17 1985-09-03 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US4378314A (en) * 1979-09-21 1983-03-29 Bristol Myers Company Antibacterial agents and metal containing azetidinone intermediates therefore
GR70784B (de) * 1979-11-02 1983-03-23 Merck & Co Inc
US4386030A (en) * 1979-12-31 1983-05-31 Merck & Co., Inc. Process for preparing 6-(1'-hydroxyethyl)-2-substituted-pen-2-em-3-carboxylic acid
PT73640B (en) * 1980-09-17 1983-10-19 Merck & Co Inc Process for preparing chemical compounds selectively inhibit the metabolism of dipeptidase
US4406902A (en) * 1980-09-17 1983-09-27 Merck & Co., Inc. Dipeptidase inhibitors
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
JPH075463B2 (ja) * 1985-03-09 1995-01-25 サントリー株式会社 抗菌剤
US4739113A (en) * 1986-05-30 1988-04-19 Merck & Co., Inc. Bis(cyclopropanecarboxamido)alkadienedioic acids as renal dipeptidase inhibitors
US5061730A (en) * 1987-01-26 1991-10-29 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid derivatives
US4866171A (en) * 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
US5061729A (en) * 1988-06-08 1991-10-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same
EP0406863B1 (de) * 1989-07-06 1995-05-24 Banyu Pharmaceutical Co., Ltd. Cyclische Derivate des Amidinylthiocarbapenems
CA2022382A1 (en) * 1989-08-02 1991-02-03 Susumu Nakagawa Piperidylthiocarbapenem derivatives

Also Published As

Publication number Publication date
EP1161947B1 (de) 2005-06-08
DE69233529T2 (de) 2005-11-24
US5637612A (en) 1997-06-10
EP0497353A3 (en) 1992-12-02
EP1161947A3 (de) 2002-07-03
EP0497353A2 (de) 1992-08-05
EP1161947A2 (de) 2001-12-12
ATE217195T1 (de) 2002-05-15
ATE297205T1 (de) 2005-06-15
US5354748A (en) 1994-10-11
EP0497353B1 (de) 2002-05-08
ES2244529T3 (es) 2005-12-16
DE69232598T2 (de) 2002-11-21
ES2176179T3 (es) 2002-12-01
DE69232598D1 (de) 2002-06-13

Similar Documents

Publication Publication Date Title
EP0656778A4 (de) Enantiomerisch reine beta-d-dioxolan-nukleoside.
AU638525B2 (en) Efa compositions and therapy
DE69318031T2 (de) Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung
AU3113693A (en) Ophthalmic pharmaceutical composition containing n-acetyl-cysteine and polyvinylalcohol
AU544790B2 (en) Epimeric azahomoerythromycin a derivatives
DE69233529D1 (de) Orale antibakterielle Zusammensetzung und Verfahren zur Verbesserung der Resorption von Penem oder Carbapenem Antibiotika im Magen-Darm-Traktus
GR3006180T3 (de)
CA2148671A1 (en) Stable Crystalline (6S)-and (6R)-Tetrahydrofolic Acid
DE69401972D1 (de) Feste Arzneimitteldosierungsform und Methode zur Verminderung des Abriebs
EP0607252A4 (en) Method of treating hiv infection.
AU690794B2 (en) Anti-inflammatory eyedrops
AU617998B2 (en) Anticoccidial composition
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
AU5707090A (en) Hair treatment composition
AU560838B2 (en) 2-fluoro alkyl thio 6 hydroxyethyl penems
TW287942B (de)
YU45383B (en) Process for obtaining coloidic basis gel containing primicine
SE8304124D0 (sv) Fluoralkylated carbapenem derivatives
ES8507147A1 (es) Un procedimiento para la preparacion de derivados del acido penicilanico 6alfa-o-6beta-sustituidos.
ATE139116T1 (de) Arzneimittel mit einem gehalt an dexpanthenol zur topischen anwendung
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
AU2776389A (en) Beta-lactam antibiotics, processes for their preparation and their use as and in medicaments
AU3612689A (en) Veterinary composition containing ampicillin and cloxacillin for treating eye infection
HU894594D0 (en) Crystalline (5r,6s)-2-(carbomyl-oxy-methyl)-6-[(1r)-hydroxi-ethyl]-2-penem-carboxylic acid and pharmaceutical preparatives containing this compounds
AU8681091A (en) A corrosion inhibitor for use in coating formulations comprising synergistic combinations of a calcium borate and an amino carboxylate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee